Navin Joneja is a partner in Blakes’ top-ranked Competition, Antitrust & Foreign Investment Group. He is a leading competition law practitioner in The Best Lawyers in Canada, The Legal 500 Canada, Legal Media Group's Guide to the World's Leading Competition and Antitrust Lawyers, and Who’s Who Legal: Canada. According to Chambers Global: The World's Leading Lawyers for Business, “Navin is an outstanding analytical thinker” who is “deeply competent with respect to agency strategy. Navin is exceptional." In 2012, he was named one of the top 40 competition lawyers under 40 worldwide by his peers and the Global Competition Review. Recent significant matters include: Standard Life in connection with its proposed acquisition by Manulife; GlaxoSmithKline in respect of its Consumer Healthcare, Vaccines and Oncology transactions with Novartis; Pearson plc in connection with the Penguin Random House joint venture; and Visa Inc. in connection with Canadian competition law matters. Navin was chair of the Canadian Bar Association, Competition Law Section’s 2015 Annual Conference and has been chair or vice-chair of numerous CBA Competition Law Section Committees. He was called to the Ontario Bar in 1998 and the New York Bar in 2000, and previously practised in Washington, DC.